MP
Manikreddy Pullagurla
About Manikreddy Pullagurla
Data last updated:
Manikreddy Pullagurla is a Director at Biophore India Pharmaceuticals Private Limited (since 2009), Director at Sionc Pharmaceuticals Private Limited (since 2009) and Director at Azico Biophore India Private Limited (since 2015), and holds 7 more current directorships. The companies operate in Pharma and Biotechnology. The 8 current companies with reported revenue have a combined latest revenue of ₹959 Cr; the largest is Biophore India Pharmaceuticals Private Limited at ₹457 Cr (FY 2025). Earlier, Manikreddy Pullagurla was a Director at Leiutis Pharmaceuticals Private Limited (2012–2021) and Director at Zystus Nutraceuticals Private Limited (2018–2021) and 1 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 22 Aug 2009 | 2007 | ₹457 Cr (FY 2025) | Active | |
| Director | 21 May 2009 | 2008 | ₹148 Cr (FY 2024) | Active | |
| Director | 11 May 2015 | 2008 | ₹140 Cr (FY 2024) | Active | |
| Director | 21 Jan 2017 | 2004 | ₹85.73 Cr (FY 2025) | Active | |
| Designated Partner | 17 May 2021 | 2021 | ₹52.13 Cr (FY 2025) | Active | |
| Director | 18 Feb 2020 | 2020 | ₹45.31 Cr (FY 2025) | Active | |
| Additional Director | 12 Mar 2025 | 2023 | ₹18.70 Cr (FY 2024) | Active | |
| Director | 05 Jul 2021 | 2021 | ₹12.08 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 10 Sep 2012 | 2012 | ₹16.75 Cr (FY 2020) | Converted To Llp | |
| Director | 23 Oct 2018 | 2018 | ₹30.6 Lakh (FY 2022) | Active | |
| Director | 18 Jul 2008 | 2008 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Manikreddy Pullagurla
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Manikreddy Pullagurla
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Manikreddy Pullagurla
Manikreddy Pullagurla currently holds 10 directorships: Biophore India Pharmaceuticals Private Limited (Director, since 22 Aug 2009, revenue ₹457 Cr (FY 2025)); Sionc Pharmaceuticals Private Limited (Director, since 21 May 2009, revenue ₹148 Cr (FY 2024)); Azico Biophore India Private Limited (Director, since 11 May 2015, revenue ₹140 Cr (FY 2024)); Zenara Pharma Private Limited (Director, since 21 Jan 2017, revenue ₹85.73 Cr (FY 2025)); Leiutis Pharmaceuticals Llp (Designated Partner, since 17 May 2021, revenue ₹52.13 Cr (FY 2025)); and 5 more.
Manikreddy Pullagurla was first appointed on 18 Jul 2008 as Director at Sahaj Life Sciences India Private Limited. The most recent appointment on record is 06 Jul 2026 at Ewings Ventures Llp.
The 8 current companies of Manikreddy Pullagurla that report revenue have a combined latest revenue of ₹959 Cr: Biophore India Pharmaceuticals Private Limited ₹457 Cr (FY 2025); Sionc Pharmaceuticals Private Limited ₹148 Cr (FY 2024); Azico Biophore India Private Limited ₹140 Cr (FY 2024); Zenara Pharma Private Limited ₹85.73 Cr (FY 2025); Leiutis Pharmaceuticals Llp ₹52.13 Cr (FY 2025); and 3 more.
Manikreddy Pullagurla held 3 earlier board appointments: Leiutis Pharmaceuticals Private Limited (Director, 10 Sep 2012 to 16 May 2021); Zystus Nutraceuticals Private Limited (Director, 23 Oct 2018 to 15 Feb 2021); Sahaj Life Sciences India Private Limited (Director, from 18 Jul 2008).
The current boards of Manikreddy Pullagurla's companies include Harcharan Singh (Biophore India Pharmaceuticals Private Limited), Jagadeesh Babu Rangisetty (Biophore India Pharmaceuticals Private Limited), Madhusudana Rao Kothapalli (Biophore India Pharmaceuticals Private Limited), Baburao Dandamudi (Sionc Pharmaceuticals Private Limited), Srikanth Dandamudi (Sionc Pharmaceuticals Private Limited), Subba Rao Jetti (Sionc Pharmaceuticals Private Limited), among others.